These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2459534)

  • 41. Central pressor action of neurotensin in conscious rats.
    Sumners C; Phillips MI; Richards EM
    Hypertension; 1982; 4(6):888-93. PubMed ID: 6815078
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TRH: cardiovascular and sympathetic modulation in brain nuclei of the rat.
    Feuerstein G; Hassen AH; Faden AI
    Peptides; 1983; 4(5):617-20. PubMed ID: 6419208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hemodynamic defense response to thyrotropin-releasing hormone injected into medial preoptic nucleus in rats.
    Sirén AL; Vonhof S; Feuerstein G
    Am J Physiol; 1991 Aug; 261(2 Pt 2):R305-12. PubMed ID: 1678932
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of prolactin-releasing peptide microinjection into the ventrolateral medulla on arterial pressure and sympathetic activity in rats.
    Horiuchi J; Saigusa T; Sugiyama N; Kanba S; Nishida Y; Sato Y; Hinuma S; Arita J
    Brain Res; 2002 Dec; 958(1):201-9. PubMed ID: 12468046
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Facilitation by procaterol, a beta-adrenoceptor agonist, of noradrenaline release in the pithed rat independently of angiotensin II formation.
    Kotsonis P; Majewski H
    Br J Pharmacol; 1994 Nov; 113(3):781-8. PubMed ID: 7858867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypothalamic involvement in the locomotor stimulant or satiety action of thyrotropin-releasing hormone and amphetamine.
    Shian LR; Wu MH; Lin MT; Ho LT
    Pharmacology; 1985; 30(5):259-65. PubMed ID: 3923502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Centrally-induced vasopressor responses to carbachol are augmented in DOCA-salt hypertensive rats.
    Takahashi H; Inoue A; Takeda K; Okajima H; Sasaki S; Iyoda I; Yoshimura M; Nakagawa M; Ijichi H
    Cardiovasc Res; 1984 Feb; 18(2):126-32. PubMed ID: 6697339
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of intracerebroventricular administration of thyrotrophic-releasing hormone on cardiovascular function in the rat.
    Tsay BL; Lin MT
    Neuroendocrinology; 1982; 35(3):173-7. PubMed ID: 6813757
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Streptozotocin diabetic rats are hypertensive despite reduced hypothalamic responsiveness.
    Buñag RD; Tomita T; Sasaki S
    Hypertension; 1982; 4(4):556-65. PubMed ID: 6218080
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Augmented sympathetic nerve activity and pressor responsiveness in DOCA hypertensive rats.
    Takeda K; Buñag RD
    Hypertension; 1980; 2(1):97-101. PubMed ID: 6102966
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of centrally administered TRH on blood pressure, heart rate and ventilation in rat.
    Koivusalo F; Paakkari I; Leppäluoto J; Karppanen H
    Acta Physiol Scand; 1979 May; 106(1):83-6. PubMed ID: 111471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of thyroid status on release of hypothalamic thyrotropin-releasing hormone.
    Rondeel JM; de Greef WJ; Visser TJ
    Horm Metab Res Suppl; 1990; 23():1-4. PubMed ID: 2120121
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of thyrotropin-releasing hormone (TRH) to thyrotropin (TSH) stimulation for evaluating thyroid function in dogs.
    Frank LA
    J Am Anim Hosp Assoc; 1996; 32(6):481-7. PubMed ID: 8906724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Centrally administered thyrotropin-releasing hormone in the regulation of regional blood flow to brown adipose tissue in rats.
    Uchida Y; Nomoto T
    Eur J Pharmacol; 1988 May; 149(3):257-65. PubMed ID: 3137079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurohumoral contributions to chronic angiotensin-induced hypertension.
    Bruner CA; Fink GD
    Am J Physiol; 1986 Jan; 250(1 Pt 2):H52-61. PubMed ID: 2867686
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Repetitive or continuous thyrotropin (TSH)-releasing hormone administration induces a biphasic rise in plasma TSH in euthyroid but not in hypothyroid rats.
    Maruta S; Greer MA
    Endocrinology; 1987 Dec; 121(6):1946-52. PubMed ID: 3119311
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasopressin antagonist in nucleus tractus solitarius/vagal area reduces pressor and tachycardia responses to paraventricular nucleus stimulation in rats.
    Pittman QJ; Franklin LG
    Neurosci Lett; 1985 May; 56(2):155-60. PubMed ID: 3925390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thyrotropin-releasing hormone (TRH) improves survival in anaphylactic shock: a central effect mediated by the sympatho-adrenomedullary beta-adrenoceptive system.
    Amir S; Harel M; Schachar A
    Brain Res; 1984 Apr; 298(2):219-24. PubMed ID: 6326950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of central angiotensin II and substance P on sympathetic nerve activity in conscious rats. Implications for cardiovascular adaptation to behavioral responses.
    Unger T; Becker H; Petty M; Demmert G; Schneider B; Ganten D; Lang RE
    Circ Res; 1985 Apr; 56(4):563-75. PubMed ID: 2579749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pressor responses to centrally-administered prostaglandin E2 in spontaneously hypertensive rats.
    Takahashi H; Buñag RD
    Hypertension; 1981; 3(4):426-32. PubMed ID: 6946962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.